These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28627686)
1. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151 [TBL] [Abstract][Full Text] [Related]
3. Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro. Erbes T; Hirschfeld M; Waldeck S; Rücker G; Jäger M; Willmann L; Kammerer B; Mayer S; Gitsch G; Stickeler E Int J Hyperthermia; 2016 Sep; 32(6):630-42. PubMed ID: 27380148 [TBL] [Abstract][Full Text] [Related]
4. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression. Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1. Li L; Qu YW; Li YP Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437 [TBL] [Abstract][Full Text] [Related]
6. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer. He Z; Xu H; Meng Y; Kuang Y Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620 [TBL] [Abstract][Full Text] [Related]
7. Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis. Chen H; Fan Y; Xu W; Chen J; Meng Y; Fang D; Wang J Oncol Rep; 2017 Jun; 37(6):3493-3501. PubMed ID: 28440476 [TBL] [Abstract][Full Text] [Related]
8. Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B. Liu P; Qi M; Ma C; Lao G; Liu Y; Liu Y; Liu Y FEBS Lett; 2013 Aug; 587(16):2523-9. PubMed ID: 23769985 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Related Tumor Acidosis Affects MicroRNA Expression Pattern in Prostate and Breast Tumor Cells. Riemann A; Reime S; Thews O Adv Exp Med Biol; 2017; 977():119-124. PubMed ID: 28685435 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC. Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827 [TBL] [Abstract][Full Text] [Related]
11. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist. Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267 [TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional Regulation of MMP16 and TIMP2 Expression Rak B; Mehlich D; Garbicz F; Domosud Z; Paskal W; Marczewska JM; Włodarski PK Cancer Genomics Proteomics; 2017; 14(5):389-401. PubMed ID: 28871006 [TBL] [Abstract][Full Text] [Related]
13. Acidic extracellular environment affects miRNA expression in tumors in vitro and in vivo. Riemann A; Reime S; Thews O Int J Cancer; 2019 Apr; 144(7):1609-1618. PubMed ID: 30098207 [TBL] [Abstract][Full Text] [Related]
14. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer. Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162 [TBL] [Abstract][Full Text] [Related]
15. Verification of microRNA expression in human endometrial adenocarcinoma. Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384 [TBL] [Abstract][Full Text] [Related]
16. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma]. Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567 [TBL] [Abstract][Full Text] [Related]
17. The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer. Yamamoto N; Nishikawa R; Chiyomaru T; Goto Y; Fukumoto I; Usui H; Mitsuhashi A; Enokida H; Nakagawa M; Shozu M; Seki N Int J Oncol; 2015 Jul; 47(1):325-34. PubMed ID: 25955017 [TBL] [Abstract][Full Text] [Related]
18. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line. Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis. Kontomanolis EN; Koukourakis MI Microrna; 2015; 4(1):18-25. PubMed ID: 26088599 [TBL] [Abstract][Full Text] [Related]
20. An integrative transcriptomic analysis reveals bisphenol A exposure-induced dysregulation of microRNA expression in human endometrial cells. Chou WC; Lee PH; Tan YY; Lin HC; Yang CW; Chen KH; Chuang CY Toxicol In Vitro; 2017 Jun; 41():133-142. PubMed ID: 28238728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]